Wuhan Hiteck Biological Pharma Co., Ltd. engages in the research, development, production, and sale of chemicals including biological products and thrombin. It offers injection of rat nerve growth factor freeze-dried powder injection and injection with anti-hepatitis B transfer factor freeze-dried powder injection. The company was founded on April 8, 1992 and is headquartered in Wuhan, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company